MedPath

Study on Postoperative Adrenal Function Assessment in Patients With Primary Aldosteronism

Not yet recruiting
Conditions
Primary Aldosteronism
Registration Number
NCT06534268
Lead Sponsor
Ruijin Hospital
Brief Summary

This study employs a prospective, single-center, open, observational research design to evaluate postoperative adrenal cortical function in patients with primary aldosteronism (PA) and to explore indicators predicting postoperative adrenal insufficiency and their predictive efficacy

Detailed Description

Patients suspected of having primary aldosteronism and admitted for treatment, who are diagnosed with primary aldosteronism through at least one confirmatory test, and subsequently diagnosed with unilateral primary aldosteronism via bilateral adrenal vein sampling and ACTH stimulation test, will undergo surgery. Those who have an ACTH stimulation test within one week postoperatively will be included in the study.

This study employs a prospective, single-center, open, observational research design to evaluate postoperative adrenal cortical function in patients with primary aldosteronism (PA) and to explore indicators predicting postoperative adrenal insufficiency and their predictive efficacy

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Patients diagnosed with unilateral primary aldosteronism who undergo surgical treatment and have their cortical function assessed by an ACTH stimulation test within one week postoperatively.
Exclusion Criteria
  • Patients using medications that affect adrenal cortical function.
  • Patients with a history of adrenal surgery
  • Pregnant or breastfeeding women
  • Patients with severe underlying diseases (such as liver or kidney failure) that may affect adrenal cortical function

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patients' baseline hormone level1day

serum hormone level

Patients' baseline glucose metabolic levels1day

0-minute、30-minute、60-minute 、120-minute and 180-minute blood glucose levels after OGTT

Participant's weight and height1 day

BMI(body mess index) in kg/m\^2= (weight in kg) /(height in m)\^2

Number of Participants with baseline glucose metabolic levels1 day

glucose metabolism, lipid metabolism, liver and kidney function, electrolytes, etc

Number of Participants with baseline lipid metabolic levels1day

blood lipid levels

The gender and age of the participants1 day

age in years and sex (female or male) of patients

Patients' hormone levels at 0 minutes and 120 minutes after preoperative ACTH stimulation test1day

cortisol and aldosterone levels

Number of Participants with baseline electrolytes levels1day

sodium, potassium, chloride, calcium, and phosphorus ion levels

Patients' hormone levels at 0 minutes and 120 minutes after postoperative ACTH stimulation test1day

cortisol and aldosterone levels

Number of Participants with baseline kidney function levels1day

Creatinine, blood urea nitrogen (BUN), and uric acid levels

Secondary Outcome Measures
NameTimeMethod
Number of Participants with changes of lipid metabolic levels after surgical management1day

blood lipid levels

the changes of glucose metabolic levels after surgical management1day

0-minute、30-minute、60-minute 、120-minute and 180-minute blood glucose levels after OGTT

the changes of hormone levels after surgical management1day

cortisol and aldosterone serum hormone level

Number of Participants with changes of kidney function levels after surgical management1 day

Creatinine, blood urea nitrogen (BUN), and uric acid levels

© Copyright 2025. All Rights Reserved by MedPath